









Markets
/
Stocks
/
nasdaq-ogi
/

OrganiGram Holdings Inc

OGI

1.530USD

+0.050+3.38%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

205.73MMarket Cap

LossP/E TTM



OrganiGram Holdings Inc

1.530

+0.050+3.38%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of OrganiGram Holdings Inc

Currency: USD Updated: 2026-02-06

Key Insights

OrganiGram Holdings Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 65 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

OrganiGram Holdings Inc's Score

Industry at a Glance

Industry Ranking

65 / 75

Overall Ranking

416 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

OrganiGram Holdings Inc Highlights

StrengthsRisks

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 55.42% year-on-year.

Undervalued

The company’s latest PE is -10.98, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 10.36M shares, decreasing 42.69% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.15.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of OrganiGram Holdings Inc is 7.07, ranking 54 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 58.21M, representing a year-over-year increase of 88.14%, while its net profit experienced a year-over-year increase of 633.97%.

Score

Industry at a Glance

Previous score

7.07

Change



Financials

6.40

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.56

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.82

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.40

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.16

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

OrganiGram Holdings Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of OrganiGram Holdings Inc is 6.05, ranking 61 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -10.98, which is -2086.46% below the recent high of 218.17 and -481.86% above the recent low of -63.90.

Score

Industry at a Glance

Previous score

6.05

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 65/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for OrganiGram Holdings Inc. The Healthcare Providers & Services industry's average is 7.58.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of OrganiGram Holdings Inc is 7.30, ranking 28 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 1.77 and the support level at 1.28, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.15

Change

0.15

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.014

Sell

RSI(14)

42.588

Neutral

STOCH(KDJ)(9,3,3)

28.939

Neutral

ATR(14)

0.076

High Vlolatility

CCI(14)

-78.531

Neutral

Williams %R

67.405

Sell

TRIX(12,20)

-0.472

Sell

StochRSI(14)

79.444

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

1.528

Buy

MA10

1.557

Sell

MA20

1.599

Sell

MA50

1.683

Sell

MA100

1.705

Sell

MA200

1.558

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

British American Tobacco plc

40.13M

+23.22%

Tidal Investments LLC

2.34M

-11.48%

Morgan Stanley & Co. LLC

1.07M

+604.00%

Global X Investments Canada Inc.

1.07M

AdvisorShares Investments, LLC

1.05M

+31.16%

Renaissance Technologies LLC

Star Investors

981.45K

-3.41%

Two Sigma Investments, LP

524.88K

+1376.47%

RBC Dominion Securities, Inc.

427.11K

+6.90%

BMO Nesbitt Burns Inc.

310.21K

+0.24%

Baader Bank AG

263.92K

+5.29%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of OrganiGram Holdings Inc is 3.09, ranking 59 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 2.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.